Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

InflaRx N.V. - Common Stock (NQ:IFRX)

0.8418 -0.0031 (-0.37%)
Streaming Delayed Price Updated: 2:47 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about InflaRx N.V. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Good morning! It's time for another dive into the biggest pre-market stock movers as we go over the news for Tuesday morning! 
Via InvestorPlace
News headline image
Why Is Kezar Life Sciences Surging By 78%? 25 Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Kezar Life Sciences, Inc. (NASDAQ: KZR) rose 78% to $10.29 in pre-market trading after the company reported positive topline results from the MISSION Phase 2 clinical trial evaluating... 
Via Benzinga
News headline image
Read Why Did Raymond James Slash Price Target On Inflarx ↗
 
Via Benzinga
News headline image
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday ↗
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
News headline image
Analyst Ratings for InflaRx ↗
Analysts have provided the following ratings for InflaRx (NASDAQ:IFRX) within the last quarter: 
Via Benzinga
News headline image
InflaRx Shares Plunge After Disappointing Results On Vilobelimab In Critically Ill COVID-19 Patients ↗
 
Via Benzinga
News headline image
Recap: InflaRx Q4 Earnings ↗
InflaRx (NASDAQ:IFRX) reported its Q4 earnings results on Thursday, March 24, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
News headline image
Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
Good morning, trader! We're starting off the week with an overview of the biggest pre-market stock movers for Monday morning! 
Via InvestorPlace
News headline image
FDA Issues Corrected Advice To InflaRx's Vilobelimab Study In Skin Disease ↗
InflaRx N.V. (NASDAQ: IFRX) has  
Via Benzinga
News headline image
Why InflaRx Shares Are Ripping Higher Thursday ↗
InflaRx N.V. (NASDAQ:IFRX) 
Via Benzinga
News headline image
Epizyme + 20 Stocks Moving In Monday's Pre-Market Session ↗
Gainers Tenax Therapeutics, Inc. (NASDAQ: TENX) rose 90.1% to $0.59 in pre-market trading after dipping more than 46% on Friday. 
Via Benzinga
News headline image
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday ↗
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation... 
Via Benzinga
News headline image
Recap: InflaRx Q1 Earnings ↗
InflaRx (NASDAQ:IFRX) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings InflaRx missed estimated earnings by... 
Via Benzinga
News headline image
53 Biggest Movers From Yesterday ↗
Gainers Longeveron Inc. (NASDAQ: LGVN) shares jumped 105.4% to close at $13.80 on Thursday after the company announced the publication of results from a Phase 1 trial testing... 
Via Benzinga
News headline image
36 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 71% to $11.57 after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients with... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
On Thursday, 92 companies hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Friday ↗
Jefferies cut the price target on MEI Pharma, Inc. (NASDAQ: MEIP) from $4 to $1. MEI Pharma shares fell 44.2% to $1.01 in pre-market trading. 
Via Benzinga
News headline image
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings ↗
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment... 
Via Benzinga
News headline image
See Why Did InflaRx Pause Late-Stage Vilobelimab Trial In Chronic Skin Condition ↗
InflaRx N.V. (NASDAQ: IFRX) has received an advice letter from the FDA about the vilobelimab Phase 3 program for hidradenitis suppurativa (HS), a condition that causes small... 
Via Benzinga
News headline image
InflaRx's Vilobelimab Shows Encouraging Action Against Rare Autoimmune Disorder ↗
InflaRx N.V. (NASDAQ: IFRX) has announced data from the European Phase II IXCHANGE study of vilobelimab in patients with ANCA-associated vasculitis (AAV). ... 
Via Benzinga
News headline image
70 Biggest Movers From Friday ↗
Gainers Everspin Technologies, Inc. (NASDAQ: MRAM) shares surged 63.2% to close at $10.74 on Friday after the company reported better-than-expected Q3 results and issued Q4... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Surges 160 Points; Wolfspeed Shares Gain After Q1 Results ↗
Toward the end of trading Thursday, the Dow traded up 0.45% to 35,651.09 while the NASDAQ rose 1.21% to 15,420.51. The S&P also rose, gaining 0.83% to 4,589.40. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
66 Biggest Movers From Yesterday ↗
Gainers HCW Biologics Inc. (NASDAQ: HCWB) shares surged 62% to close at $4.73 on Thursday after the company announced that it has been cleared by the U.S. Food and Drug... 
Via Benzinga
News headline image
Mid-Day Market Update: Nasdaq Rises Over 1%; Rafael Holdings Shares Slide ↗
Midway through trading Thursday, the Dow traded up 0.40% to 35,631.75 while the NASDAQ rose 1.09% to 15,401.19. The S&P also rose, gaining 0.74% to 4,585.17. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021 ↗
Upgrades For Boot Barn Holdings Inc (NYSE: 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Rise; Caterpillar Profit Beats Expectations ↗
Following the market opening Thursday, the Dow traded up 0.53% to 35,678.96 while the NASDAQ rose 0.95% to 15,380.23. The S&P also rose, gaining 0.76% to 4,586.39. The U.S.... 
Via Benzinga
Topics Stocks
News headline image
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In... 
Via Benzinga
News headline image
30 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers InflaRx N.V. (NASDAQ: IFRX) rose 47.9% to $4.23 in pre-market trading. Raymond James upgraded InflaRx from Outperform to Strong Buy and announced a $14 price target.... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.